Funder: National Institutes of Health

Due Dates: April 4, 2025 | October 3, 2025

Funding Amounts: Up to $150,000/year (direct costs) for up to 3 years; estimated 4 awards; total program funding ~$1M/year.

Summary: Supports early-stage development of innovative technologies to improve the quality and handling of biospecimens for cancer research and clinical care.

Key Information: Clinical trials are not allowed; projects must focus on technical innovation, not biological hypothesis testing.